FDA's draft guidance shows gene therapy developers how to use prior knowledge and platform data to accelerate regulatory ...
Intravacc offers state-of-the-art analytical methods for identity, content, purity, structure, formulation, stability, and preclinical ...
This is part one of a two-part article offering proposals to improve the FDA’s guidance to implement a new approval framework for individualized genetic therapies based on a “plausible mechanism” of ...
A strategic CDMO partnership brings together scientific expertise, manufacturing capabilities, and shared goals to advance ...
Counsel advising acquirers in pharmaceutical, biotechnology, and medical device transactions must assess a target's compliance with Food and ...
SHELTON, CT / ACCESS Newswire / June 8, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the “Company”), a clinical stage leader developing antiviral drugs that viruses cannot escape, NanoViricides ...
AdvanCell strengthens its leadership team with key U.S. appointments and continued investment in isotope innovation and platform growth.
Realize safe, scalable, and compliant cell therapies by building analytical strategies that exceed regulatory expectations.
Ultra-rare diseases often lack patient populations large enough to support randomized controlled trials. The question is not ...
Shilpa Medicare Ltd has entered a strategic equity partnership with Gate2Brain, S.L., a biotechnology company focused on CNS therapeutics.
Advancing microbiology QC in biomanufacturing requires new technologies, strong cross-functional practices, and collaboration ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results